In the rapidly evolving landscape of metabolic medicine, Eli Lilly’s experimental drug, retatrutide, has emerged as a...
Chemotherapy and Targeted Therapy
The high-stakes battle for dominance in the burgeoning obesity medication market has reached a new inflection point....
In a landmark development for regenerative medicine, Cellular Intelligence—a high-profile startup formerly known as Somite AI—has secured...
In the high-stakes arena of immunology and dermatology, Apogee Therapeutics is making a compelling case for a...
In a move that signals a renewed appetite for late-stage biotechnology offerings, Kardigan, a cardiovascular-focused startup founded...
The biotechnology sector is experiencing a profound renaissance. Following a period of economic recalibration, the industry is...
In a major shift that signals both the growing pains of artificial intelligence in medicine and a...
The modern narrative surrounding obesity treatment has been dominated by a singular, pharmaceutical phenomenon: the rise of...
The global pharmaceutical landscape underwent a seismic shift in fiscal year 2025. While the leaderboard continues to...
In a landmark deal that underscores the seismic shift occurring within the pharmaceutical industry, Insilico Medicine announced...
